Abstract:Background: Pre-eclampsia (PE) is a pregnancy complication associated with maternal and fetal morbidity and mortality. Among the potential pathogenesis discussed, inflammation is considered an essential initiator of PE. Previous studies have compared the levels of various inflammatory biomarkers that indicate the existence of PE; however, the relative levels of pro-inflammatory and anti-inflammatory biomarkers and their dynamic changes during PE progression remain unclear. This knowledge is essential to explain the occurrence and progression of the disease. Objective: We aimed to identify the relationship between inflammatory status and PE using inflammatory biomarkers as indicators. We also discussed the underlying mechanism by which inflammatory imbalance contributes to PE by comparing the relative levels of pro-inflammatory and anti-inflammatory biomarkers. Furthermore, we identified additional risk factors for PE. Methods: We reviewed PubMed, Embase, and the Cochrane Library for articles published until 15 th September 2022. Original articles that investigated inflammatory biomarkers in PE and normal pregnancy were included. We selected healthy pregnant women as controls. The inflammatory biomarkers in the case and control groups were expressed as standardized mean differences and 95% confidence intervals using a random-effects model. Study quality was assessed using the Newcastle-Ottawa Scale. Publication bias was assessed using Egger's test. Results: Thirteen articles that investigated 2,549 participants were included in this meta-analysis. Patients with PE had significantly higher levels of C-reactive protein (CRP), interleukin (IL)-4, IL-6, IL-8, IL-10, and tumor necrosis factor (TNF) than the controls. CRP and pro-inflammatory cytokine levels were higher than those of anti-inflammatory cytokines. Patients with gestational age > 34 weeks had significantly higher IL-6 and TNF levels. Patients with higher systolic blood pressure had significantly higher IL-8, IL-10, and CRP levels. Conclusion: Inflammatory imbalance is an independent risk factor for PE development. Impairment of the anti-inflammatory system is a crucial initiating factor for PE development. Failed autoregulation, manifested as prolonged exposure to pro-inflammatory cytokines, leads to PE progression. Higher levels of inflammatory biomarkers suggest more severe symptoms, and pregnant women after 34 weeks of gestation are more susceptible to PE.

Systematic review of the complement components as potential biomarkers of pre-eclampsia: pitfalls and opportunities

Protective role of complement factor H against the development of preeclampsia

Dysregulation of complement system during pregnancy in patients with preeclampsia: A prospective study.

COVID-19, Pre-Eclampsia, and Complement System

Preliminary study on the role of human defensins, interleukins and PCSK9 in early and late preeclampsia

Expression of the Complement System's Activation Factors in Plasma of Patients with Early/late‐onset Severe Pre‐eclampsia

OS 23-02 THE ROLE OF COMPLEMENT C5a-MEDIATED PLACENTAL DYSFUNCTION IN THE ONSET OF PREECLAMPSIA

Correlations between complement system's activation factors and anti-angiogenesis factors in plasma of patients with early/late-onset severe preeclampsia.

The Role of Inflammatory Biomarkers in the Development and Progression of Pre-eclampsia: a Systematic Review and Meta-Analysis

From Biomarkers to the Molecular Mechanism of Preeclampsia-A Comprehensive Literature Review

Dysregulated complement activation in early-onset severe preeclampsia and late-onset severe preeclampsia

Complement 5A-Mediated Trophoblasts Dysfunction is Involved in the Development of Pre-Eclampsia

Circulating extracellular vesicles and neutrophil extracellular traps contribute to endothelial dysfunction in preeclampsia

Serum markers of pre-eclampsia identified on proteomics.

Circulating Immune Cells from Early- and Late-onset Pre-eclampsia Displays Distinct Profiles with Differential Impact on Endothelial Activation

A Review of Key Cytokines Based on Gene Polymorphism in the Pathogenesis of Pre‐eclampsia

Microparticles in Preeclampsia during Pregnancy: A Systematic Review and Meta-analysis

Circulating Microsome Proteins in the Pathogenesis of Preeclampsia

Autoantibody-Mediated Complement C3a Receptor Activation Contributes to the Pathogenesis of Preeclampsia

Pre-Eclampsia: Re-visiting Pathophysiology, Role of immune cells in Pre-Eclampsia, Biomarker identification and recent advances in its Management

Serum Levels of Complement Factors C1q, Bb, and H in Normal Pregnancy and Severe Pre-Eclampsia